8-K: WhiteHorse Finance Faces Nasdaq Listing Non-Compliance After Director's Passing

WhiteHorse Finance has received a notice from Nasdaq for not meeting the independent director requirement following the death of a board member.

Summary

• WhiteHorse Finance, Inc. has reported the passing of independent director Kevin F. Burke on January 13, 2024.
• Mr. Burke had served on the board since 2017 and was a member of the Audit, Compensation, and Nominating and Corporate Governance Committees.
• Following Mr. Burke's death, the board now has six members, with only three being independent directors.
• This composition does not meet Nasdaq's listing rule 5605, which requires a majority of independent directors.
• The company received a notice from Nasdaq on January 24, 2024, regarding this non-compliance.
• Nasdaq has provided a cure period for WhiteHorse Finance to regain compliance.
• The cure period extends until the earlier of the next annual shareholders meeting or January 16, 2025.
• If the next annual shareholders meeting is before July 15, 2024, the company must evidence compliance by July 15, 2024.
• WhiteHorse Finance is actively working to regain compliance within the given cure period.

Sentiment

Score: 3

Explanation: The document reports a negative event (loss of a director) leading to a compliance issue, which is concerning for investors. However, the company is taking steps to rectify the situation.

Positives

• Nasdaq has provided a cure period for WhiteHorse Finance to regain compliance.
• The company is actively working to regain compliance with the majority independent board requirement.

Negatives

• The company is currently not in compliance with Nasdaq's independent director requirement.
• The loss of a key board member has triggered a compliance issue.

Risks

• Failure to regain compliance within the cure period could result in further action from Nasdaq.
• The company needs to appoint a new independent director to meet the listing requirements.

Future Outlook

The company plans to regain compliance with Nasdaq's listing rules within the provided cure period.

Management Comments

• WhiteHorse Finance, Inc. is deeply saddened to announce that director Kevin F. Burke passed away.

Industry Context

This announcement highlights the importance of corporate governance and board composition for publicly listed companies, and the need to adhere to exchange listing rules.

Comparison to Industry Standards

• Nasdaq listing rules require a majority of independent directors, which is a common standard for publicly traded companies in the US.
• Many companies such as Ares Capital Corporation (ARCC) and Main Street Capital Corporation (MAIN) also adhere to similar corporate governance standards.
• Failure to meet these standards can lead to delisting or other penalties, which is why WhiteHorse Finance is taking steps to rectify the situation.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the company's non-compliance with Nasdaq listing rules.
• The company's reputation could be affected by this issue.

Next Steps

• The company needs to appoint a new independent director.
• The company must evidence compliance with Nasdaq listing rules within the cure period.

Key Dates

Keywords

Nasdaq, independent directors, compliance, corporate governance, listing rules, board of directors, WhiteHorse Finance